Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300075123Phase 4Suspended
Phase 4, randomised trial in Procedural anxiety, major depressive disorder (MDD), Insomnia and 1 more comparing Esketamine group with Sufentanil group (2 arms). Primary endpoint: Patient and operator satisfaction score. Started Jun 2023; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300075123.